{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T04:46:01Z","timestamp":1790484361547,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004837","name":"Spanish Ministry of Science and Innovation","doi-asserted-by":"publisher","award":["MAT2014-59134-R"],"award-info":[{"award-number":["MAT2014-59134-R"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Spanish Ministry of Science and Innovation","doi-asserted-by":"publisher","award":["BES-2012-056083"],"award-info":[{"award-number":["BES-2012-056083"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Spanish Ministry of Science and Innovation","doi-asserted-by":"publisher","award":["2014SGR-1023"],"award-info":[{"award-number":["2014SGR-1023"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Portuguese Science and Technology Foundation, Ministry of Science and Education"},{"DOI":"10.13039\/501100002924","name":"FEDER","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002924","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.ejpb.2016.10.009","type":"journal-article","created":{"date-parts":[[2016,10,24]],"date-time":"2016-10-24T18:32:32Z","timestamp":1477333952000},"page":"70-75","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":150,"special_numbering":"C","title":["Lipid nanoparticles (SLN, NLC): Overcoming the anatomical and physiological barriers of the eye \u2013 Part I \u2013 Barriers and determining factors in ocular delivery"],"prefix":"10.1016","volume":"110","author":[{"given":"E.","family":"S\u00e1nchez-L\u00f3pez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Espina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Doktorovova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.B.","family":"Souto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.L.","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2016.10.009_b0005","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/mabi.201100419","article-title":"Nanomaterials for ocular drug delivery","volume":"12","author":"Liu","year":"2012","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.ejpb.2016.10.009_b0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2012.00188","article-title":"Ocular drug delivery: a clue from nanotechnology","volume":"3","author":"Bucolo","year":"2012","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejpb.2016.10.009_b0015","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.preteyeres.2013.02.001","article-title":"Molecular basis of the inner blood-retinal barrier and its breakdown in diabetic macular edema and other pathological conditions","volume":"34","author":"Klaassen","year":"2013","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.ejpb.2016.10.009_b0020","doi-asserted-by":"crossref","first-page":"47","DOI":"10.5497\/wjp.v2.i2.47","article-title":"Ocular drug delivery systems: an overview","volume":"2","author":"Patel","year":"2013","journal-title":"World J. Pharmacol."},{"key":"10.1016\/j.ejpb.2016.10.009_b0025","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1016\/j.addr.2005.09.004","article-title":"Topical and systemic drug delivery to the posterior segments","volume":"57","author":"Hughes","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2016.10.009_b0030","doi-asserted-by":"crossref","first-page":"5306","DOI":"10.1002\/jps.21383","article-title":"PLGA nanospheres for the ocular delivery of flurbiprofen: drug release and interactions","volume":"97","author":"Vega","year":"2008","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2016.10.009_b0035","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ejpb.2015.01.026","article-title":"Biopharmaceutical profile of pranoprofen-loaded PLGA nanoparticles containing hydrogels for ocular administration","volume":"95","author":"Abrego","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2016.10.009_b0040","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.colsurfb.2016.04.054","article-title":"PEGylated PLGA nanospheres optimized by design of experiments for ocular administration of dexibuprofen\u2013 in vitro, ex vivo and in vivo characterization","volume":"145","author":"S\u00e1nchez-L\u00f3pez","year":"2016","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.ejpb.2016.10.009_b0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2011\/863734","article-title":"Recent applications of liposomes in ophthalmic drug delivery","volume":"2011","author":"Mishra","year":"2011","journal-title":"J. Drug Deliv."},{"key":"10.1016\/j.ejpb.2016.10.009_b0050","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ejmech.2009.10.017","article-title":"Designing dendrimers for ocular drug delivery","volume":"45","author":"Spataro","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejpb.2016.10.009_b0055","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1007\/s11095-010-0159-x","article-title":"Biodegradable implants for sustained drug release in the eye","volume":"27","author":"Lee","year":"2010","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2016.10.009_b0060","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.clae.2007.09.002","article-title":"Polymeric hydrogels for novel contact lens-based ophthalmic drug delivery systems: a review","volume":"31","author":"Xinming","year":"2008","journal-title":"Contact Lens Anterior Eye"},{"key":"10.1016\/j.ejpb.2016.10.009_b0065","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ijpharm.2007.03.011","article-title":"Nanosuspension as an ophthalmic delivery system for certain glucocorticoid drugs","volume":"340","author":"Kassem","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2016.10.009_b0070","doi-asserted-by":"crossref","first-page":"4038","DOI":"10.1167\/iovs.07-0066","article-title":"Coated microneedles for drug delivery to the eye","volume":"48","author":"Jiang","year":"2007","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ejpb.2016.10.009_b0075","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2174\/1874126600802010061","article-title":"Designing of a thermosensitive chitosan\/poloxamer in situ gel for ocular delivery of ciprofloxacin","volume":"2","author":"Varshosaz","year":"2008","journal-title":"Open Drug Deliv. J."},{"key":"10.1016\/j.ejpb.2016.10.009_b0080","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1146\/annurev-fluid-120710-101058","article-title":"Fluid mechanics of the eye","volume":"44","author":"Siggers","year":"2012","journal-title":"Annu. Rev. Fluid Mech."},{"key":"10.1016\/j.ejpb.2016.10.009_b0085","series-title":"Adv. Organ Biol. Biol. Eye","first-page":"291","article-title":"Innative and adaptative immunity of the eye","author":"Mogens Holst","year":"2006"},{"key":"10.1016\/j.ejpb.2016.10.009_b0090","doi-asserted-by":"crossref","first-page":"252","DOI":"10.3390\/pharmaceutics4020252","article-title":"Breakdown of the blood-ocular barrier as a strategy for the systemic use of nanosystems","volume":"4","author":"Occhiutto","year":"2012","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2016.10.009_b0095","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.jconrel.2015.09.065","article-title":"Delivery strategies for treatment of age-related ocular diseases: from a biological understanding to biomaterial solutions","volume":"219","author":"Delplace","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2016.10.009_b0100","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1517\/17425247.2011.628983","article-title":"Strategies for therapy of retinal diseases using systemic drug delivery: relevance of transporters at the blood\u2013retinal barrier","volume":"8","author":"Hosoya","year":"2011","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ejpb.2016.10.009_b0105","series-title":"Ocul. Transp. Recept. Role Drug Deliv.","first-page":"1","article-title":"Eye: anatomy, physiology and barriers to drug delivery","author":"Cholkar","year":"2013"},{"key":"10.1016\/j.ejpb.2016.10.009_b0110","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1517\/17425247.3.2.275","article-title":"Ocular drug delivery","volume":"3","author":"Ghate","year":"2006","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ejpb.2016.10.009_b0115","doi-asserted-by":"crossref","first-page":"507","DOI":"10.2174\/1389200043335342","article-title":"Role of metabolism in ocular drug delivery","volume":"5","author":"Duvvuri","year":"2004","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.ejpb.2016.10.009_b0120","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1089\/jop.2012.0200","article-title":"Novel strategies for anterior segment ocular drug delivery","volume":"29","author":"Cholkar","year":"2013","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.ejpb.2016.10.009_b0125","doi-asserted-by":"crossref","first-page":"710","DOI":"10.3109\/10717544.2014.923065","article-title":"Colloidal drug delivery system: amplify the ocular delivery","volume":"23","author":"Ameeduzzafar","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ejpb.2016.10.009_b0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0024513","article-title":"Sustained release of an anti-glaucoma drug: demonstration of efficacy of a liposomal formulation in the rabbit eye","volume":"6","author":"Natarajan","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ejpb.2016.10.009_b0135","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1517\/17425247.5.5.567","article-title":"Ocular novel drug delivery: impacts of membranes and barriers","volume":"5","author":"Barar","year":"2008","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ejpb.2016.10.009_b0140","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0168-3659(90)90122-A","article-title":"Mechanisms and facilitation of corneal drug penetration","volume":"11","author":"Lee","year":"1990","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2016.10.009_b0145","first-page":"1","article-title":"Improved and safe transcorneal delivery of flurbiprofen by NLC and NLC-based hydrogels","volume":"99","author":"Gonzalez-Mira","year":"2012","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2016.10.009_b0150","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2174\/1877912311202020082","article-title":"Novel nanomicellar formulation approaches for anterior and posterior segment ocular drug delivery","volume":"2","author":"Cholkar","year":"2012","journal-title":"Recent Patents Nanomed."},{"key":"10.1016\/j.ejpb.2016.10.009_b0155","first-page":"684","article-title":"Paracellular permeability of corneal and conjunctival epithelia","volume":"30","author":"Huang","year":"1989","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ejpb.2016.10.009_b0160","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.freeradbiomed.2004.04.030","article-title":"Impairment of conjunctival glutathione secretion and ion transport by oxidative stress in an adenovirus type 5 ocular infection model of pigmented rabbits","volume":"37","author":"Kannan","year":"2004","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejpb.2016.10.009_b0165","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1023\/A:1007508714259","article-title":"Role of P-glycoprotein in restricting propranolol transport in cultured rabbit conjunctival epithelial cell layers","volume":"17","author":"Yang","year":"2000","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2016.10.009_b0170","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1080\/10837450902891295","article-title":"Drug metabolism and pharmacokinetics","volume":"41","author":"Benedetti","year":"2009","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.ejpb.2016.10.009_b0175","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1006\/rtph.1998.1243","article-title":"Binding of drugs to eye melanin is not predictive of ocular toxicity","volume":"28","author":"Leblanc","year":"1998","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.ejpb.2016.10.009_b0180","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1208\/s12248-010-9183-3","article-title":"Ocular drug delivery","volume":"12","author":"Gaudana","year":"2010","journal-title":"AAPS J."},{"key":"10.1016\/j.ejpb.2016.10.009_b0185","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.ejps.2012.03.013","article-title":"Ex vivo models to evaluate the role of ocular melanin in trans-scleral drug delivery","volume":"46","author":"Pescina","year":"2012","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2016.10.009_b0190","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0014-4835(77)80009-2","article-title":"The structural basis of the blood-ocular barriers","volume":"25","author":"Raviola","year":"1977","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.ejpb.2016.10.009_b0195","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1586\/eop.09.70","article-title":"Drug delivery to the posterior segment of the eye for pharmacologic therapy","volume":"5","author":"Shah","year":"2010","journal-title":"Expert Rev. Ophthalmol."},{"key":"10.1016\/j.ejpb.2016.10.009_b0200","first-page":"1","article-title":"Advances in ocular drug delivery: emphasis on the posterior segment","volume":"5247","author":"Kang-Mieler","year":"2014","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ejpb.2016.10.009_b0205","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.drudis.2010.12.004","article-title":"Drug delivery to the posterior segment of the eye","volume":"16","author":"Thrimawithana","year":"2011","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejpb.2016.10.009_b0210","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1159\/000108117","article-title":"Transport barriers in transscleral drug delivery for retinal diseases","volume":"39","author":"Kim","year":"2007","journal-title":"Ophthalmic Res."},{"key":"10.1016\/j.ejpb.2016.10.009_b0215","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.addr.2006.07.027","article-title":"Challenges and obstacles of ocular pharmacokinetics and drug delivery","volume":"58","author":"Urtti","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2016.10.009_b0220","series-title":"Biodrug Deliv. Syst. Fundam. Appl. Clin. Dev","first-page":"187","article-title":"Ocular delivery systems: transscleral drug delivery to the posterior eye segment","author":"Urtti","year":"2010"},{"key":"10.1016\/j.ejpb.2016.10.009_b0225","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0169-409X(95)00010-5","article-title":"Ocular absorption following topical delivery","volume":"16","author":"Jarvinen","year":"1995","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2016.10.009_b0230","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.drudis.2007.10.021","article-title":"Nanotechnology in ocular drug delivery","volume":"13","author":"Sahoo","year":"2008","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejpb.2016.10.009_b0235","first-page":"609","article-title":"Conjugation of cell-penetrating peptides with poly (lactic-co-glycolic acid)-polyethylene glycol nanoparticles improves ocular drug delivery","volume":"10","author":"Vasconcelos","year":"2015","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ejpb.2016.10.009_b0240","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0378-5173(02)00080-7","article-title":"Solid lipid nanoparticles (SLN) as ocular delivery system for tobramycin","volume":"238","author":"Cavalli","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2016.10.009_b0245","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.colsurfb.2012.08.021","article-title":"Further investigation of nanostructured lipid carriers as an ocular delivery system: in vivo transcorneal mechanism and in vitro release study","volume":"102","author":"Tian","year":"2013","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.ejpb.2016.10.009_b0250","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.drudis.2012.10.005","article-title":"Recent advances in topical ophthalmic drug delivery with lipid-based nanocarriers","volume":"18","author":"Gan","year":"2013","journal-title":"Drug Discov. Today."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641116307238?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641116307238?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T22:13:35Z","timestamp":1601158415000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641116307238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":50,"alternative-id":["S0939641116307238"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2016.10.009","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipid nanoparticles (SLN, NLC): Overcoming the anatomical and physiological barriers of the eye \u2013 Part I \u2013 Barriers and determining factors in ocular delivery","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2016.10.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}